Shandong Weigao Group Medical Polymer Co. Ltd. ADS (SHWGY)
Shandong Weigao Group Medical Polymer Co. Ltd. ADS (SHWGY) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Shandong Weigao Group Medical Polymer Co. Ltd. ADS
Fiscal year is January-December. All values HKD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.13B 2.83B 3.83B 4.54B 5.82B
Cost of Goods Sold (COGS) incl. D&A 998.98M 1.27B 1.71B 1.94B 2.38B
COGS excluding D&A 909.98M 1.16B 1.59B 1.77B 2.13B
Depreciation & Amortization Expense 89M 114M 124.97M 170.06M 251.09M
Depreciation 81.3M 104.41M 113.92M 153.95M 233.22M
Amortization of Intangibles 7.7M 3.57M 3.75M 3.83M 3.93M
Gross Income 1.13B 1.56B 2.12B 2.59B 3.44B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 566.23M 872.87M 1.1B 1.54B 2.12B
Research & Development 88.14M 114.84M 171.04M 209.71M 263.6M
Other SG&A 478.09M 758.03M 932.19M 1.33B 1.86B
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 2.66M 8.23M - -
EBIT after Unusual Expense 0 (2.66M) (8.23M) - -
Non Operating Income/Expense 71.31M 140.16M 3.15B 122.1M (698.45M)
Non-Operating Interest Income 6.8M 6.4M 7.76M 25.19M 8.23M
Equity in Affiliates (Pretax) - - - - -
Interest Expense 4.54M 11.09M 1.38M 5.75M 11.3M
Gross Interest Expense 8.09M 12.31M 5.34M 6.18M 20.53M
Interest Capitalized 3.55M 1.22M 3.97M 433,968 9.23M
Pretax Income 639.99M 792.84M 4.14B 1.18B 604.37M
Income Tax 81.45M 98.18M 149.9M 159.58M 197.43M
Income Tax - Current Domestic 83.75M 101.19M 153.81M 170.21M 195.45M
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (2.29M) (3.01M) (3.92M) (10.63M) 1.98M
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 159.97M 226.36M 182.16M 207.13M 82.19M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 718.5M 921.02M 4.18B 1.22B 489.14M
Minority Interest Expense (778,439) 3.77M 7.06M (142,607) (384,824)
Net Income 719.28M 917.26M 4.17B 1.23B 489.53M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 719.28M 917.26M 4.17B 1.23B 489.53M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 719.28M 917.26M 4.17B 1.23B 489.53M
EPS (Basic) 0.17 0.21 0.94 0.27 0.11
Basic Shares Outstanding 4.31B 4.31B 4.42B 4.48B 4.48B
EPS (Diluted) 0.17 0.21 0.94 0.27 0.11
Diluted Shares Outstanding 4.31B 4.31B 4.42B 4.48B 4.48B
EBITDA 655.42M 798.37M 1.14B 1.22B 1.57B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
OUTFRONT Media’s Earnings Drumroll Heading toward that red-letter date of November 5, OUTFRONT Media (NYSE: OUT) has got its ducks in a row. They're ready to spill the beans on third-quarter numbers after close of market—just as clocks hit 4:30 p.m. Eastern. It’s showtime, folks. What’s at Stake? We're talking OUTFRONT Media—one of the big kahunas in out-of-home...
Continue Reading
Fresenius Takes a Giant Leap in Kidney Care Fresenius Medical Care is breaking new ground in the U.S., marking a significant milestone with the introduction of the multiFiltratePRO System for critically ill patients battling acute kidney injury (AKI). This isn't some run-of-the-mill equipment upgrade. It's an evolution in how critical care teams manage continuous kidney...
Continue Reading
Eightpoint Technologies Steps Up for a Crucial Cause Kicking in when it counts, Eightpoint Technologies has done something that might not turn stock market heads but speaks volumes about corporate responsibility. They're ponying up for a year's worth of groceries for the Cayman Islands Crisis Centre (CICC) starting November 1, 2026. We're talking real relief for women and...
Continue Reading
Unlocking the Secrets of First Dental Visits When should little ones start showing up in that dental chair? You might be thinking, "I'll wait until they actually have a full set of chompers," but that's a rookie move, folks. A piece coming out of HelloNation suggests parents hustle those kiddos into the dentist's office by their first birthday or six months after the...
Continue Reading
Delisting Drama: Navigating Direct Digital's Market Move Looks like Direct Digital Holdings is getting caught up in the whirlwind of delisting and deregistering its Class A common stock from the Nasdaq. This move isn't just about hopping off a big exchange—it’s a whole new set of dance steps in the market. Timing and Mechanics of the Departure They’ve set their...
Continue Reading
Fresh Bites of Opportunity at PrimoHoagies Head down to Philly and you'll catch wind of a tasty venture cooking up some buzz: PrimoHoagies is diving into 2026 with seven fresh franchisees under their wing. What you've got here isn't some scrappy startup grasping at straws, but a solid name packing over three decades under its belt. When experienced restaurant operators...
Continue Reading
Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...
Continue Reading
Gathering for a Greater Cause in Chicago The American Liver Foundation (ALF) hosted a summit in the Windy City that was as much about heart as it was about livers. This wasn’t just another sterile conference; it was a grassroots rally for those battling metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated steatotic liver disease...
Continue Reading
A Robust Third Quarter Samsung Biologics is making some serious noise in the biopharma sector with its latest Q3 2026 financial results. We're talking about KRW 1,490 billion in revenue, an uptick that screams growth, backed by an operating profit of KRW 640 billion. What's fueling this engine? Their relentless plant expansion and a pivotal step into the U.S. market....
Continue Reading
From Thrill to Touch: The Glint Debut Screw the traditional remote control for sex toys! Lovense is straight up flipping the script with Glint. This isn't about adding more buttons or connecting another app. We're talking about a butt plug that lets your partner's thrust set the whole vibe. Forget fumbling with phones in the heat of the moment—this toy syncs your...
Continue Reading
Top 5 Most Recently Viewed Articles
The Remarkable Growth of KKR Over the Past Decade Investing in KKR (NYSE: KKR) ten years ago would have been a smart move for any investor. Throughout this decade, KKR has consistently outperformed market expectations, achieving an impressive annualized return of 19.49%. This standout performance exceeds the market average by 8.29%, highlighting the potential of strategic...
Continue Reading
Enhancing Communication with Therap's T-Log Module Therap Services, a prominent player in the realm of HIPAA-compliant electronic documentation solutions, is committed to empowering agencies within the Long-Term Services and Supports (LTSS), Home and Community-Based Services (HCBS), and various other human services sectors. With the introduction of its innovative T-Log...
Continue Reading
BioMarin Unveils New Funding Strategy for Expansion BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) recently announced its successful pricing of a significant offering of $850 million in senior unsecured notes, due 2034. These notes carry a fixed interest rate of 5.500%, with an issue price set at 100.000%. The anticipated closing date for this offering is just around the...
Continue Reading
Piramal Pharma Limited Financial Results Overview Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635) has announced compelling results for the third quarter (Q3) and the first nine months (9M) of FY25, highlighting a strong performance in the pharmaceutical and wellness sectors. Consolidated Financial Highlights The company reported significant financial metrics, with...
Continue Reading
Five Star Development Takes Steps for Project Protection Five Star Development, LLC, alongside affiliated entities, has recently announced its decision to file for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court. This pivotal move aims to ensure that the ambitious project known as The Palmeraie, which includes The Ritz-Carlton Paradise Valley, can be...
Continue Reading